SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-010061
Filing Date
2021-10-18
Accepted
2021-10-18 16:41:39
Documents
13
Period of Report
2021-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_101521.htm   iXBRL 8-K 28208
2 PRESS RELEASE DATED OCTOBER 18, 2021 ex99-1.htm EX-99.1 24322
  Complete submission text file 0001387131-21-010061.txt   234077

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE admp-20211015.xsd EX-101.SCH 3001
4 XBRL LABEL FILE admp-20211015_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE admp-20211015_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_101521_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 211328677
SIC: 2834 Pharmaceutical Preparations